[HTML][HTML] Combined intravitreal ranibizumab and oral supplementation with docosahexaenoic acid and antioxidants for diabetic macular edema: Two-year randomized …
M Lafuente, L Ortín, M Argente, JL Guindo… - Retina, 2017 - journals.lww.com
Purpose: To assess the 2-year effectiveness of intravitreal ranibizumab combined with a
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
[PDF][PDF] Two-Year Randomized Single-Blind Controlled Trial Results
M LAFUENTE, L ORTÍN, M ARGENTE, JL GUINDO… - RETINA, 2017 - brudylab.net
Purpose: To assess the 2-year effectiveness of intravitreal ranibizumab combined with a
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
COMBINED INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR …
M Lafuente, L Ortín, M Argente, JL Guindo… - Retina, 2017 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose:</jats: title>< jats: p> To assess the 2-year effectiveness
of intravitreal ranibizumab combined with a dietary supplement rich in docosahexaenoic …
of intravitreal ranibizumab combined with a dietary supplement rich in docosahexaenoic …
Combined intravitreal ranibizumab and oral supplementation with docosahexaenoic acid and antioxidants for diabetic macular edema: two-year randomized single …
M Lafuente, L Ortín, M Argente, JL Guindo… - 2017 - cabidigitallibrary.org
Purpose: To assess the 2-year effectiveness of intravitreal ranibizumab combined with a
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
[PDF][PDF] Two-Year Randomized Single-Blind Controlled Trial Results
M LAFUENTE, L ORTÍN, M ARGENTE, JL GUINDO… - RETINA, 2017 - academia.edu
Purpose: To assess the 2-year effectiveness of intravitreal ranibizumab combined with a
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
COMBINED INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR …
M Lafuente, L Ortín, M Argente, JL Guindo… - Retina (Philadelphia …, 2017 - europepmc.org
Purpose To assess the 2-year effectiveness of intravitreal ranibizumab combined with a
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
COMBINED INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR …
M Lafuente, L Ortín, M Argente, JL Guindo… - Retina, 2017 - hero.epa.gov
PURPOSE: To assess the 2-year effectiveness of intravitreal ranibizumab combined with a
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
COMBINED INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR …
M Lafuente, L Ortín, M Argente, JL Guindo… - 2017 - pubmed.ncbi.nlm.nih.gov
Purpose To assess the 2-year effectiveness of intravitreal ranibizumab combined with a
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …
dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with …